PubMed ID:
21300066
Public Release Type:
Journal
Publication Year: 2011
Affiliation: Mayo Clinic, Rochester, Minnesota, USA.
DOI:
https://doi.org/10.1053/j.gastro.2011.01.046
Authors:
Abell T,
Abell TL,
Atkinson M,
Baxter L,
Belt P,
Bernard C,
Bernard CE,
Bishop R,
Calles J,
Calles J,
Coleski R,
Colvin R,
Culler S,
DeVole N,
Doma S,
Donithan M,
Farrugia G,
Farrugia G,
Faussone-Pellegrini MS,
Fordham J,
Gomez J,
Greene M,
Green M,
Grover M,
Grover M,
Hamilton F,
Hamilton FA,
Harbison S,
Hasler W,
Hasler WL,
Hejazi R,
Henry O,
Hooker J,
Isaacson M,
James S,
Kantor S,
Kedar A,
Kendrick M,
Kim W,
Koch K,
Koch KL,
Lee L,
Lee L,
Louiseau S,
Lurken M,
Lurken MS,
Lydecker A,
Lytes V,
Mann P,
Marincek A,
McCallum RW,
McNair V,
Miriel L,
Nguyen L,
Nguyen L,
NIDDK Gastroparesis Clinical Research Consortium,
Palit A,
Parker S,
Parkman HP,
Parkman HP,
Pasricha PJ,
Pasricha PJ,
Pillor E,
Ponsetto C,
Pruett S,
Ramzan Z,
Sachdeva P,
Sarosiek I,
Sarr M,
Shen K,
Shetler K,
Simmons K,
Smith M,
Smyrk TC,
Snape W,
Snape WJ,
Spree D,
Sternberg A,
Tonascia J,
Tonascia J,
Torrance R,
Ullah N,
Ünalp-Arida A,
Ünalp-Arida A,
Van Natta M,
Van Raaphorst R,
Vasquez D,
Vaughn I,
Vega N,
Wilson L,
Yates K
Studies:
Gastroparesis Clinical Research Consortium
,
Nortriptyline for Idiopathic Gastroparesis
Cellular changes associated with diabetic and idiopathic gastroparesis are not well described. The aim of this study was to describe histologic abnormalities in gastroparesis and compare findings in idiopathic versus diabetic gastroparesis.